HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B.

Abstract
Osteosarcoma (OS) is a highly malignant bone tumor and the prognosis for non-responders to chemotherapy remains poor. Previous studies have shown that human sarcomas contain sarcoma-initiating cells (SIC), which have the characteristics of high tumorigenesis and resistance to chemotherapy. In the present study, we characterized SIC of a novel OS cell line, screened for SIC-related genes, and tried to regulate the proliferation of OS by metabolic interference. Initially, we established a new human OS cell line (OS13) and isolated clones showing higher tumorigenesis as SIC (OSHIGH ) and counterpart clones. OSHIGH cells showed chemoresistance and their metabolism highly depended on aerobic glycolysis and suppressed oxidative phosphorylation. Using RNA-sequencing, we identified LIN28B as a SIC-related gene highly expressed in OSHIGH cells. mRNA of LIN28B was expressed in sarcoma cell lines including OS13, but its expression was not detectable in normal organs other than the testis and placenta. LIN28B protein was also detected in various sarcoma tissues. Knockdown of LIN28B in OS13 cells reduced tumorigenesis, decreased chemoresistance, and reversed oxidative phosphorylation function. Combination therapy consisting of a glycolysis inhibitor and low-dose chemotherapy had antitumor effects. In conclusion, manipulation of glycolysis combined with chemotherapy might be a good adjuvant treatment for OS. Development of immunotherapy targeting LIN28B, a so-called cancer/testis antigen, might be a good approach.
AuthorsEmi Mizushima, Tomohide Tsukahara, Makoto Emori, Kenji Murata, Asuka Akamatsu, Yuji Shibayama, Shuto Hamada, Yuto Watanabe, Mitsunori Kaya, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Toshihiko Yamashita, Noriyuki Sato, Toshihiko Torigoe
JournalCancer science (Cancer Sci) Vol. 111 Issue 1 Pg. 36-46 (Jan 2020) ISSN: 1349-7006 [Electronic] England
PMID31705593 (Publication Type: Journal Article)
Copyright© 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • LIN28B protein, human
  • RNA, Messenger
  • RNA-Binding Proteins
Topics
  • Animals
  • Bone Neoplasms (genetics, pathology)
  • Carcinogenesis (genetics, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (genetics)
  • Glycolysis (genetics)
  • Humans
  • Male
  • Mice
  • Mice, Inbred NOD
  • Osteosarcoma (genetics, pathology)
  • Oxidative Phosphorylation
  • Placenta (pathology)
  • Pregnancy
  • Prognosis
  • RNA, Messenger (genetics)
  • RNA-Binding Proteins (genetics)
  • Testis (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: